Innovation for Life

Developing Innovative drugs, Biosimilars, Platforms, and Diagnostic technologies to improve lives.

Advancing Antibody Science

Advancing antibody drugs and biosimilars to address unmet medical needs.

Creating Value for a Healthier Life

Improving patient access through cost-effective, high-quality biosimilars.

PRESTIGE BIOPHARMA

PRESTIGE BIOPHARMA IDC

PRESTIGE BIOLOGICS

7

Beyond technological discovery, expanding access to care for patients around the world

Innovative Drug

Development of First-in-Class therapeutics for unmet diseases

Biosimilar

Prominent Biosimilars pipelines for accelerating market access

Platform Technology

A drug delivery platform that enhances treatment convenience

Diagnostics

Diagnostics for Pancreatic cancer by detecting PAUF

Prestige News

Total 66
Number Thumbnail Title Author Date Votes Views
56 IDC Expands Asset Value to Over 200 Billion KRW… "Accelerating Commercialization on the Back of Financial Stability"
we******** | 2026.05.11 | Votes 0 | Views 1077
we******** 2026.05.11 0 1077
55 BJFEZ Expands ‘Insight Trip’ Program to High School Students: “Discovering the Future On-Site”
we******** | 2026.04.29 | Votes 0 | Views 864
we******** 2026.04.29 0 864
54 Prestige Biopharma IDC Files Patent for Next-Generation Antibody Delivery Platform ‘IDC224’
김** | 2026.04.21 | Votes 0 | Views 1276
김** 2026.04.21 0 1276
53 BJFEZ Advances Open Innovation Campus for AI-Driven Drug Development
김** | 2026.04.13 | Votes 0 | Views 882
김** 2026.04.13 0 882
52 Prestige Biopharma's Avastin Biosimilar HD204 Nears Regulatory Approval and Commercialization
김** | 2026.03.24 | Votes 0 | Views 1564
김** 2026.03.24 0 1564
51 Prestige Biopharma IDC Signs Strategic Research Collaboration Agreement with Pusan National University Medical Research Institu
김** | 2026.02.25 | Votes 0 | Views 730
김** 2026.02.25 0 730
50 Prestige Biopharma IDC Files Patent for Bispecific Antibody Targeting Cytokine Storm–Related Inflammatory Diseases
김** | 2026.02.24 | Votes 0 | Views 730
김** 2026.02.24 0 730
49 Prestige Biopharma IDC Obtains ISO 9001 Certification for Global Quality Management System
김** | 2026.01.29 | Votes 0 | Views 580
김** 2026.01.29 0 580
48 Prestige Biopharma IDC Files Patent for PBP1710 Targeting Fibrotic Diseases
김** | 2026.01.23 | Votes 0 | Views 609
김** 2026.01.23 0 609
47 Prestige Biopharma Secures U.S. Patent for Novel Anticancer Antibody PBP1710
김** | 2025.12.08 | Votes 0 | Views 591
김** 2025.12.08 0 591

Read Prestige news >>